New Edge Advisors, LLC Tekla Life Sciences Investors Transaction History
New Edge Advisors, LLC
- $16.2 Billion
- Q1 2025
A detailed history of New Edge Advisors, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, New Edge Advisors, LLC holds 32,500 shares of HQL stock, worth $397,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,500
Previous 22,715
43.08%
Holding current value
$397,800
Previous $298,000
38.26%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.06MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.19MShares$39 Million1.12% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.14 Million0.17% of portfolio
-
Morgan Stanley New York, NY519KShares$6.35 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY468KShares$5.72 Million0.25% of portfolio
-
Needham Investment Management LLC New York, NY379KShares$4.63 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...